Children with standard-risk B-lineage acute lymphoblastic leukemia can be safely spared from at least some of the toxicity associated with anthracyclines, according to data presented at the American Society of Hematology. Neil Osterweil interviews Dr. Andre Baruchel, one of the study's investigators. For ongoing ASH coverage, visit http://www.oncologyreport.com.
Thanks! Share it with your friends!
Children with standard-risk B-lineage acute lymphoblastic leukemia can be safely spared from at least some of the toxicity associated with anthracyclines, according to data presented at the American Society of Hematology. Neil Osterweil interviews Dr. Andre Baruchel, one of the study’s investigators. For ongoing ASH coverage, visit http://www.oncologyreport.com.
![Chronic Pain Attack [Oh my God, babe??] [Public Place] [Let's Get You Home]](https://i.ytimg.com/vi/3UPe96zlzpk/hqdefault_live.jpg "Chronic Pain Attack [Oh my God, babe??] [Public Place] [Let's Get You Home]")
){kind=link}
Comments